Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Anel

Showing results (11-20 of 99) with videos related to

Pageof 10
Sort By:
Frontiers in Cell and Developmental Biology|May 2, 2019
Immunogenic Cell Death and Immunotherapy of Multiple MyelomaAlfonso Serrano-Del Valle, Alberto Anel, Javier Naval, et al.
Leukemia Research|April 18, 2015
Liposome-bound TRAIL induces superior DR5 clustering and enhanced DISC recruitment in histiocytic lymphoma U937 cellsDiego De Miguel, Ana Gallego-Lleyda, Alberto Anel, et al.
International Journal of Molecular Sciences|May 15, 2018
Lipid Nanoparticles Decorated with TNF-Related Aptosis-Inducing Ligand (TRAIL) Are More Cytotoxic than Soluble Recombinant TRAIL in SarcomaAna Gallego-Lleyda, Diego De Miguel, Alberto Anel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 10, 2009
Protein kinase C-theta is required for NK cell activation and in vivo control of tumor progressionJuan I Aguiló, Johan Garaude, Julián Pardo, et al.
Journal of Clinical Medicine|January 21, 2023
DR5 Up-Regulation Induced by Dichloroacetate Sensitizes Tumor Cells to Lipid Nanoparticles Decorated with TRAILJoaquín Marco-Brualla, Diego de Miguel, Luis Martínez-Lostao, et al.
Biomedicines|November 27, 2021
Antibody-Based Immunotoxins for Colorectal Cancer TherapyLaura Sanz, Raquel Ibáñez-Pérez, Patricia Guerrero-Ochoa, et al.
Cells|March 11, 2023
Study of the Bcl-2 Interactome by BiFC Reveals Differences in the Activation Mechanism of Bax and BakÓscar Gonzalo, Andrea Benedi, Laura Vela, et al.
Methods in Cell Biology|June 11, 2026
Flow cytometry evaluation of cytotoxicity exerted by effector immune cells against tumor cellsCristina Ripollés-Yuba, David Giraldos, Evelyn Galano-Frutos, et al.
Cancers|April 3, 2019
Importance of TRAIL Molecular Anatomy in Receptor Oligomerization and Signaling. Implications for Cancer TherapyJavier Naval, Diego de Miguel, Ana Gallego-Lleyda, et al.
Experimental Cell Research|April 28, 2007
Membrane expression of DR4, DR5 and caspase-8 levels, but not Mcl-1, determine sensitivity of human myeloma cells to Apo2L/TRAILMaria Gómez-Benito, Maria José Martinez-Lorenzo, Alberto Anel, et al.
Pageof 10

Showing results (11-20 of 99) with videos related to

Sort By:
Pageof 10
Frontiers in Cell and Developmental Biology|May 2, 2019
Immunogenic Cell Death and Immunotherapy of Multiple MyelomaAlfonso Serrano-Del Valle, Alberto Anel, Javier Naval, et al.
Leukemia Research|April 18, 2015
Liposome-bound TRAIL induces superior DR5 clustering and enhanced DISC recruitment in histiocytic lymphoma U937 cellsDiego De Miguel, Ana Gallego-Lleyda, Alberto Anel, et al.
International Journal of Molecular Sciences|May 15, 2018
Lipid Nanoparticles Decorated with TNF-Related Aptosis-Inducing Ligand (TRAIL) Are More Cytotoxic than Soluble Recombinant TRAIL in SarcomaAna Gallego-Lleyda, Diego De Miguel, Alberto Anel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 10, 2009
Protein kinase C-theta is required for NK cell activation and in vivo control of tumor progressionJuan I Aguiló, Johan Garaude, Julián Pardo, et al.
Journal of Clinical Medicine|January 21, 2023
DR5 Up-Regulation Induced by Dichloroacetate Sensitizes Tumor Cells to Lipid Nanoparticles Decorated with TRAILJoaquín Marco-Brualla, Diego de Miguel, Luis Martínez-Lostao, et al.
Biomedicines|November 27, 2021
Antibody-Based Immunotoxins for Colorectal Cancer TherapyLaura Sanz, Raquel Ibáñez-Pérez, Patricia Guerrero-Ochoa, et al.
Cells|March 11, 2023
Study of the Bcl-2 Interactome by BiFC Reveals Differences in the Activation Mechanism of Bax and BakÓscar Gonzalo, Andrea Benedi, Laura Vela, et al.
Methods in Cell Biology|June 11, 2026
Flow cytometry evaluation of cytotoxicity exerted by effector immune cells against tumor cellsCristina Ripollés-Yuba, David Giraldos, Evelyn Galano-Frutos, et al.
Cancers|April 3, 2019
Importance of TRAIL Molecular Anatomy in Receptor Oligomerization and Signaling. Implications for Cancer TherapyJavier Naval, Diego de Miguel, Ana Gallego-Lleyda, et al.
Experimental Cell Research|April 28, 2007
Membrane expression of DR4, DR5 and caspase-8 levels, but not Mcl-1, determine sensitivity of human myeloma cells to Apo2L/TRAILMaria Gómez-Benito, Maria José Martinez-Lorenzo, Alberto Anel, et al.
Pageof 10